Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Predictors of one-year mortality after hospitalization for an exacerbation of COPD.

Esteban C, Castro-Acosta A, Alvarez-Martínez CJ, Capelastegui A, López-Campos JL, Pozo-Rodriguez F.

BMC Pulm Med. 2018 Jan 25;18(1):18. doi: 10.1186/s12890-018-0574-z.

2.

Multi-level differential network analysis of COPD exacerbations.

Noell G, Cosío BG, Faner R, Monsó E, Peces-Barba G, de Diego A, Esteban C, Gea J, Rodriguez-Roisin R, Garcia-Nuñez M, Pozo-Rodriguez F, Kalko SG, Agustí A.

Eur Respir J. 2017 Sep 27;50(3). pii: 1700075. doi: 10.1183/13993003.00075-2017. Print 2017 Sep.

3.

Accuracy of COPD Diagnosis During an Admission: The European Perspective.

Lopez-Campos JL, Castro-Acosta A, Pozo-Rodriguez F, Hartl S, Roberts CM.

Chest. 2017 Jun;151(6):1396-1397. doi: 10.1016/j.chest.2017.01.044. No abstract available.

PMID:
28599931
4.

Understanding variation in length of hospital stay for COPD exacerbation: European COPD audit.

Ruparel M, López-Campos JL, Castro-Acosta A, Hartl S, Pozo-Rodriguez F, Roberts CM.

ERJ Open Res. 2016 Mar 5;2(1). pii: 00034-2015. eCollection 2016 Jan.

5.

Persistence of Breakage in Specific Chromosome Bands 6 Years after Acute Exposure to Oil.

Francés A, Hildur K, Barberà JA, Rodríguez-Trigo G, Zock JP, Giraldo J, Monyarch G, Rodriguez-Rodriguez E, de Castro Reis F, Souto A, Gómez FP, Pozo-Rodríguez F, Templado C, Fuster C.

PLoS One. 2016 Aug 1;11(8):e0159404. doi: 10.1371/journal.pone.0159404. eCollection 2016.

6.

Risk of death and readmission of hospital-admitted COPD exacerbations: European COPD Audit.

Hartl S, Lopez-Campos JL, Pozo-Rodriguez F, Castro-Acosta A, Studnicka M, Kaiser B, Roberts CM.

Eur Respir J. 2016 Jan;47(1):113-21. doi: 10.1183/13993003.01391-2014. Epub 2015 Oct 22.

7.

Clinical audit: why, where and how?

Pozo-Rodríguez F, Castro-Acosta AA, Álvarez-Martínez CJ.

Arch Bronconeumol. 2015 Oct;51(10):479-80. doi: 10.1016/j.arbres.2015.05.006. Epub 2015 Aug 12. English, Spanish. No abstract available.

8.

Molecular and clinical diseasome of comorbidities in exacerbated COPD patients.

Faner R, Gutiérrez-Sacristán A, Castro-Acosta A, Grosdidier S, Gan W, Sánchez-Mayor M, Lopez-Campos JL, Pozo-Rodriguez F, Sanz F, Mannino D, Furlong LI, Agusti A.

Eur Respir J. 2015 Oct;46(4):1001-10. doi: 10.1183/13993003.00763-2015. Epub 2015 Aug 6.

9.

Follow-Up Genotoxic Study: Chromosome Damage Two and Six Years after Exposure to the Prestige Oil Spill.

Hildur K, Templado C, Zock JP, Giraldo J, Pozo-Rodríguez F, Frances A, Monyarch G, Rodríguez-Trigo G, Rodriguez-Rodriguez E, Souto A, Gómez FP, Antó JM, Barberà JA, Fuster C.

PLoS One. 2015 Jul 29;10(7):e0132413. doi: 10.1371/journal.pone.0132413. eCollection 2015.

10.

The Effect of Incidental Consolidation on Management and Outcomes in COPD Exacerbations: Data from the European COPD Audit.

Saleh A, López-Campos JL, Hartl S, Pozo-Rodríguez F, Roberts CM; European COPD Audit team.

PLoS One. 2015 Jul 27;10(7):e0134004. doi: 10.1371/journal.pone.0134004. eCollection 2015.

11.

Antibiotic Prescription for COPD Exacerbations Admitted to Hospital: European COPD Audit.

López-Campos JL, Hartl S, Pozo-Rodriguez F, Roberts CM; European COPD Audit team.

PLoS One. 2015 Apr 23;10(4):e0124374. doi: 10.1371/journal.pone.0124374. eCollection 2015.

12.

Determinants of between-hospital variations in outcomes for patients admitted with COPD exacerbations: findings from a nationwide clinical audit (AUDIPOC) in Spain.

Pozo-Rodríguez F, Castro-Acosta A, Alvarez CJ, López-Campos JL, Forte A, López-Quilez A, Agustí A, Abraira V; AUDIPOC Study Group.

Int J Clin Pract. 2015 Sep;69(9):938-47. doi: 10.1111/ijcp.12601. Epub 2015 Feb 4.

13.

Results from an audit feedback strategy for chronic obstructive pulmonary disease in-hospital care: a joint analysis from the AUDIPOC and European COPD audit studies.

Lopez-Campos JL, Asensio-Cruz MI, Castro-Acosta A, Calero C, Pozo-Rodriguez F; AUDIPOC and the European COPD Audit studies.

PLoS One. 2014 Oct 15;9(10):e110394. doi: 10.1371/journal.pone.0110394. eCollection 2014.

14.

MicroRNA-dependent regulation of transcription in non-small cell lung cancer.

Molina-Pinelo S, Gutiérrez G, Pastor MD, Hergueta M, Moreno-Bueno G, García-Carbonero R, Nogal A, Suárez R, Salinas A, Pozo-Rodríguez F, Lopez-Rios F, Agulló-Ortuño MT, Ferrer I, Perpiñá A, Palacios J, Carnero A, Paz-Ares L.

PLoS One. 2014 Mar 13;9(3):e90524. doi: 10.1371/journal.pone.0090524. eCollection 2014.

15.

Chromosomal bands affected by acute oil exposure and DNA repair errors.

Monyarch G, de Castro Reis F, Zock JP, Giraldo J, Pozo-Rodríguez F, Espinosa A, Rodríguez-Trigo G, Verea H, Castaño-Vinyals G, Gómez FP, Antó JM, Coll MD, Barberà JA, Fuster C.

PLoS One. 2013 Nov 26;8(11):e81276. doi: 10.1371/journal.pone.0081276. eCollection 2013.

16.

Evaluation of the persistence of functional and biological respiratory health effects in clean-up workers 6 years after the prestige oil spill.

Zock JP, Rodríguez-Trigo G, Rodríguez-Rodríguez E, Souto-Alonso A, Espinosa A, Pozo-Rodríguez F, Gómez FP, Fuster C, Castaño-Vinyals G, Antó JM, Barberà JA.

Environ Int. 2014 Jan;62:72-7. doi: 10.1016/j.envint.2013.09.020. Epub 2013 Oct 26.

PMID:
24184661
17.

Variability of hospital resources for acute care of COPD patients: the European COPD Audit.

López-Campos JL, Hartl S, Pozo-Rodriguez F, Roberts CM; European COPD Audit team.

Eur Respir J. 2014 Mar;43(3):754-62. doi: 10.1183/09031936.00074413. Epub 2013 Aug 29.

18.

European hospital adherence to GOLD recommendations for chronic obstructive pulmonary disease (COPD) exacerbation admissions.

Roberts CM, Lopez-Campos JL, Pozo-Rodriguez F, Hartl S; European COPD Audit team.

Thorax. 2013 Dec;68(12):1169-71. doi: 10.1136/thoraxjnl-2013-203465. Epub 2013 Jun 1.

PMID:
23729193
19.

Quality of care assessment in COPD. AUDIPOC: the Spanish audit experience.

Lopez-Campos JL, Pozo-Rodríguez F; AUDIPOC Study Group.

Pneumonol Alergol Pol. 2012;80(6):505-8. No abstract available.

20.

Clinical audit of COPD patients requiring hospital admissions in Spain: AUDIPOC study.

Pozo-Rodríguez F, López-Campos JL, Alvarez-Martínez CJ, Castro-Acosta A, Agüero R, Hueto J, Hernández-Hernández J, Barrón M, Abraira V, Forte A, Sanchez Nieto JM, Lopez-Gabaldón E, Cosío BG, Agustí A; AUDIPOC Study Group.

PLoS One. 2012;7(7):e42156. Epub 2012 Jul 31.

21.

European COPD Audit: design, organisation of work and methodology.

López-Campos JL, Hartl S, Pozo-Rodriguez F, Roberts CM; European COPD Audit team.

Eur Respir J. 2013 Feb;41(2):270-6. doi: 10.1183/09031936.00021812. Epub 2012 May 17.

22.

Persistent respiratory symptoms in clean-up workers 5 years after the Prestige oil spill.

Zock JP, Rodríguez-Trigo G, Rodríguez-Rodríguez E, Espinosa A, Pozo-Rodríguez F, Gómez F, Fuster C, Castaño-Vinyals G, Antó JM, Barberà JA.

Occup Environ Med. 2012 Jul;69(7):508-13. doi: 10.1136/oemed-2011-100614. Epub 2012 Apr 26.

PMID:
22539655
23.

Health effects of oil spills: lessons from the Prestige.

Zock JP, Rodríguez-Trigo G, Pozo-Rodríguez F, Barberà JA.

Am J Respir Crit Care Med. 2011 Nov 15;184(10):1094-6. doi: 10.1164/rccm.201102-0328ED. No abstract available.

PMID:
21719754
24.

Health changes in fishermen 2 years after clean-up of the Prestige oil spill.

Rodríguez-Trigo G, Zock JP, Pozo-Rodríguez F, Gómez FP, Monyarch G, Bouso L, Coll MD, Verea H, Antó JM, Fuster C, Barberà JA; SEPAR-Prestige Study Group.

Ann Intern Med. 2010 Oct 19;153(8):489-98. doi: 10.7326/0003-4819-153-8-201010190-00279. Epub 2010 Aug 23.

PMID:
20733177
25.

[Clinical audit of patients admitted to hospital in Spain due to exacerbation of COPD (AUDIPOC study): method and organisation].

Pozo-Rodríguez F, Alvarez CJ, Castro-Acosta A, Melero Moreno C, Capelastegui A, Esteban C, Hernández Carcereny C, López-Campos JL, Izquierdo Alonso JL, López Quílez A, Agustí A; por el Grupo AUDIPOC España.

Arch Bronconeumol. 2010 Jul;46(7):349-57. doi: 10.1016/j.arbres.2010.04.004. Epub 2010 May 31. Spanish.

26.

Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial.

Aarsland D, Ballard C, Walker Z, Bostrom F, Alves G, Kossakowski K, Leroi I, Pozo-Rodriguez F, Minthon L, Londos E.

Lancet Neurol. 2009 Jul;8(7):613-8. doi: 10.1016/S1474-4422(09)70146-2. Epub 2009 Jun 10.

PMID:
19520613
27.

Loss of the mitochondrial bioenergetic capacity underlies the glucose avidity of carcinomas.

López-Ríos F, Sánchez-Aragó M, García-García E, Ortega AD, Berrendero JR, Pozo-Rodríguez F, López-Encuentra A, Ballestín C, Cuezva JM.

Cancer Res. 2007 Oct 1;67(19):9013-7.

28.

Prolonged respiratory symptoms in clean-up workers of the prestige oil spill.

Zock JP, Rodríguez-Trigo G, Pozo-Rodríguez F, Barberà JA, Bouso L, Torralba Y, Antó JM, Gómez FP, Fuster C, Verea H; SEPAR-Prestige Study Group.

Am J Respir Crit Care Med. 2007 Sep 15;176(6):610-6. Epub 2007 Jun 7.

PMID:
17556713
29.

[Bronchioloalveolar carcinoma in Spain: a rare and different form of lung cancer].

López Encuentra A, Pozo Rodríguez F, Martín de Nicolás JL, Villena V, Sayas Catalán J; Grupo Cooperativo de Carcinoma Broncogénico de la Sociedad Española de Neumología y Cirugía y Torácica (GCCB-S).

Arch Bronconeumol. 2006 Aug;42(8):399-403. Spanish.

30.

Accuracy of helical computed tomography and [18F] fluorodeoxyglucose positron emission tomography for identifying lymph node mediastinal metastases in potentially resectable non-small-cell lung cancer.

Pozo-Rodríguez F, Martín de Nicolás JL, Sánchez-Nistal MA, Maldonado A, García de Barajas S, Calero-García R, Pozo MA, Martín-Escribano P, Martín-García I, García-Lujan R, Lopez-Encuentra A, Arenas de Pablo A.

J Clin Oncol. 2005 Nov 20;23(33):8348-56. Epub 2005 Oct 11.

PMID:
16219937
31.

Surgical lung cancer. Risk operative analysis.

López-Encuentra A, Pozo-Rodríguez F, Martín-Escribano P, Martín de Nicolás JL, Díaz de Atauri MJ, Palomera J, Marrón C.

Lung Cancer. 2004 Jun;44(3):327-37.

PMID:
15140546
32.

[Evidence-based medicine. A perspective from the clinic].

Pozo Rodríguez F.

Med Clin (Barc). 1999;112 Suppl 1:12-6. Review. Spanish. No abstract available.

PMID:
10618794
33.

[Requisites for accreditation of teaching units in pneumology].

Alvarez- Sala Walther JL, Sánchez Gascón F, Viejo Bañuelos JL, Verea Hernando HR, Pérez Martí M, Rodríguez Roisin R, Picado Vallés C, Blanquer Olivas J, Pozo Rodríguez F, Villarino Marzo MA, Esparza Morera R.

Arch Bronconeumol. 1996 Mar;32(3):142-4. Spanish. No abstract available.

PMID:
8634793
34.

Factors associated with pathogenicity of oils related to the toxic oil syndrome epidemic in Spain.

Posada de la Paz M, Philen RM, Abaitua Borda I, Diez Ruiz-Navarro M, Abraira Santos V, Pozo Rodríguez F, Pla Mestre R, Pollán Santamaría M, Sicilia Socias JM, Azpeitia Gamazo P, et al.

Epidemiology. 1994 Jul;5(4):404-9.

PMID:
7918809
35.

[The efficacy of diagnostic tests (II)].

Pozo Rodríguez F.

Med Clin (Barc). 1988 Jun 25;91(5):177-83. Review. Spanish. No abstract available.

PMID:
3050319
36.

[The efficacy of diagnostic tests (I)].

Pozo Rodríguez F.

Med Clin (Barc). 1988 May 14;90(19):779-85. Spanish. No abstract available.

PMID:
3172881
37.

[Myocarditis in legionnaires' disease].

Gutiérrez Rodero F, Ortiz de la Tabla Ducasse V, Pozo Rodríguez F, Calle Díez A, Damiano Rivero A.

Med Clin (Barc). 1985 May 18;84(19):784-6. Spanish. No abstract available.

PMID:
4033252
38.

Idiopathic pulmonary haemosiderosis treated by plasmapheresis.

Pozo-Rodriguez F, Freire-Campo JM, Gutierrez-Millet V, Barbosa-Ayúcar C, Diaz de Atauri J, Martín-Escribano P.

Thorax. 1980 May;35(5):399-400. No abstract available.

Supplemental Content

Loading ...
Support Center